Arvinas (ARVN) Other Non Operating Income (2017 - 2026)
Arvinas (ARVN) posted quarterly Other Non Operating Income of -$100000.0 for Q1 2026, up 66.67% quarter-over-quarter from -$300000.0 in Q2 2025.
Powered by 
Analysis
Arvinas (ARVN) Other Non Operating Income (2017 - 2026) Analysis & Trends
Arvinas' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$100000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income changed N/A year-over-year to -$100000.0; the TTM figure through Mar 2026 stood at -$400000.0 (up 86.21% YoY), while the FY2025 annual figure was -$400000.0, up 86.21% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$100000.0, up from -$300000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $600000.0 in Q4 2022, with the low at -$2.6 million in Q3 2024.
- The 5-year median for Other Non Operating Income is -$100000.0 (2022), against an average of -$390909.1.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income slipped 25.0% in 2022, then slumped 1000.0% in 2023.
- Arvinas' Other Non Operating Income stood at $600000.0 in 2022, then slumped by 116.67% to -$100000.0 in 2023, then sank by 100.0% to -$200000.0 in 2024, then slumped by 50.0% to -$300000.0 in 2025, then soared by 66.67% to -$100000.0 in 2026.
- Business Quant data shows ARVN's Other Non Operating Income at -$100000.0 in Q1 2026, -$300000.0 in Q2 2025, and -$200000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Arvinas | 604.91 Mn | 37.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -100,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | -2.60 Mn |
| Jun 30, 2024 | -100,000.00 |
| Dec 31, 2023 | -100,000.00 |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 1.20 Mn |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 144,215.00 |
| Jun 30, 2020 | 307,743.00 |
| Mar 31, 2020 | 390,009.00 |
| Dec 31, 2019 | 595,443.00 |